Confirm the exact entity
An expert pathology review can clarify a rare diagnosis or distinguish it from a common cancer with unusual features. Preserve the slides, tissue blocks and original molecular reports so another center can review the same evidence.
Choose relevant expertise
Ask whether the team regularly treats the specific histology, how difficult cases are discussed and whether care can be shared with your local clinicians. A large general cancer program does not necessarily have equal experience in every rare tumor.
Assess the evidence in context
Evidence may come from small studies or trials enrolling several cancers with a shared molecular target. Ask how closely the study population matches the diagnosis and prior treatment, and what is known about benefit and toxicity.
Explore relevant diagnoses
Advanced therapies & clinical trials
When reviewing a new option, separate the evidence for the treatment from the practical route to receive it. An approval in one country does not establish availability or eligibility elsewhere.
| Option | What to verify |
|---|---|
| Approved treatment | Exact indication, age group, treatment line, biomarker requirements and the current local prescribing information. |
| Clinical trial | Recruiting site, inclusion and exclusion criteria, prior therapies, travel and follow-up requirements. Participation is not guaranteed. |
| Off-label or special access | Clinical rationale, local legal route, risks, costs and the treating institution’s ability to provide follow-up. |
Preparing for a second opinion
A second opinion is especially useful when pathology is uncertain, several treatment paths are possible, disease has returned or a new therapy is being considered. Coordinate timing with the treating team so necessary care is not delayed.
- Pathology report and access to tissue slides or blocks
- Imaging reports and the actual scans, with dates
- Molecular and biomarker reports, including the test method
- Treatment names, dates, response and major side effects
- Current medicines, other conditions and the questions you want answered
Sources & content updates
This guide brings together current cancer classification and treatment information from the clinical sources below, with practical questions for specialist review.
National Cancer Institute: Rare cancers